Punch Newspapers
Sections
IT
is heartening that efforts are ongoing to develop a vaccine for Lassa fever. An American biotechnology company, INOVIO, which is spearheading the research, noted that the first participant in Lassa vaccine trial had been dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever. The clinical trial in progress in Ghana is reportedly focusing on offering precisely-designed DNA medicines to treat and protect people from infectious diseases and cancer.
Lassa fever, according to the United States Centres for Disease Control and Prevention, is an animal-borne, or zoonotic, acute viral illness. It is endemic in parts of West Africa, including Sierra Leone, Liberia, Guinea and Nigeria. The illness was discovered in 1969 and is named after the town in Nigeria where the first cases occurred. The CDC says an estimated 100,000 to 300,000 infections of Lassa fever occur annually, with approximately 5,000 deaths. The World Health O
There s need for standardised dosage for Ivermectin in COVID-19 management – Punch Newspapers
punchng.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from punchng.com Daily Mail and Mail on Sunday newspapers.
Over 40m Nigerians infected with COVID-19, survey shows
guardian.ng - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from guardian.ng Daily Mail and Mail on Sunday newspapers.
Facing Roadblocks, Vast Global Vaccination Effort Gets Underway
An operation to supply billions of coronavirus vaccine doses to poorer countries has started. But as rich countries buy most of the available supply, stark inequalities remain.
The first shipment of Covid-19 vaccines distributed by the Covax facility arriving at Kotoka International Airport in Accra, Ghana.Credit.Francis Kokoroko/UNICEF
Feb. 24, 2021
DAKAR, Senegal A long-awaited global sharing program designed to make vaccine access more equal began on Wednesday, when hundreds of thousands of doses arrived in the West African nation of Ghana the first of two billion that organizers hope to deliver worldwide this year.